NextGen Group

The American Society for Mass Spectrometry has named University of Wisconsin-Madison researcher Josh Coon winner of its Klaus Biemann Medal.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – UK-based NextGen Group announced this week it has completed the formation of a diagnostics subsidiary to develop tests for central nervous system disorders.

This story originally ran on Feb. 2.
Protein biomarker firm NextGen Group said this week that it has entered a convertible loan agreement with Alpha 4 Concepts for the provision of additional funding of €800,000 ($1.05 million).

Citing lower than expected sales in its biomarker and testing business, protein biomarker firm NextGen Group said this week it has entered a convertible loan agreement with Alpha 4 Concepts for the provision of additional funding of £650,000 ($1.04 million).

This story has been updated to correct a statement regarding H1 revenues from NextGen's biomarker qualification panels.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.

Retraction Watch's Ivan Oransky and Adam Marcus report that Harvard Medical School and Brigham and Women's Hospital have recommended that more than 30 papers from a former researcher be retracted.

Thomas Steitz, who won the 2009 chemistry Nobel Prize for his ribosome work, has died, the Washington Post reports.

In PLOS this week: mechanisms for genes implicated in coronary artery disease, rumen microbes and host genetics influence cow methane production, and more.